Insights

  • Home
  • Insights
  • The Approval and Substitutability of Biosimilars: Potential Impact on Use and Competition, Food and Drug Law Institute, Update: Enforcement Issue

Share

The Approval and Substitutability of Biosimilars: Potential Impact on Use and Competition, Food and Drug Law Institute, Update: Enforcement Issue

November 01, 2016 External Publications
You May Also Be Interested In

December 23, 2024 White Paper

Antitrust/M&A Year-in-Review 2024

December 19, 2024 Commentary

French CSPLA Report Highlights AI Regulation: Transparency and Copyright Compliance in Focus

December 13, 2024 White Paper

Class Actions Worldview Compendium

December 04, 2024 Newsletters

The Climate Report | Fourth Quarter 2024

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.